Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Borrow

Showing results (101-110 of 403) with videos related to

Pageof 41
Sort By:
Vaccine|February 12, 2022
Timing of meningococcal vaccination with 4CMenB (Bexsero®) in children with invasive meningococcal group B (MenB) disease in EnglandShamez N Ladhani, Helen Campbell, Zahin Amin-Chowdhury, et al.
The Journal of Infection|August 4, 2020
Methods to evaluate serogroup B meningococcal vaccines: From predictions to real-world evidenceRay Borrow, Muhamed-Kheir Taha, Marzia Monica Giuliani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 2013
Polysaccharide-specific memory B cells generated by conjugate vaccines in humans conform to the CD27+IgG+ isotype-switched memory B Cell phenotype and require contact-dependent signals from bystander T cells activated by bacterial proteins to differentiate into plasma cellsEdward T Clarke, Neil A Williams, Jamie Findlow, et al.
Archives of Disease in Childhood|December 17, 2015
Enter B and W: two new meningococcal vaccine programmes launchedShamez N Ladhani, Mary Ramsay, Ray Borrow, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 2, 2016
Presentation with gastrointestinal symptoms and high case fatality associated with group W meningococcal disease (MenW) in teenagers, England, July 2015 to January 2016Helen Campbell, Sydel R Parikh, Ray Borrow, et al.
Human Vaccines & Immunotherapeutics|August 27, 2020
Vaccines and routine immunization strategies during the COVID-19 pandemicEner Cagri Dinleyici, Ray Borrow, Marco Aurélio Palazzi Safadi, et al.
Vaccine|November 26, 2018
Concomitant administration of a fully liquid ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal ACWY conjugate vaccine in toddlersTimo Vesikari, Ray Borrow, Xavier Da Costa, et al.
Vaccine|August 13, 2013
Effectiveness of meningococcal serogroup C vaccine programmesRay Borrow, Raquel Abad, Caroline Trotter, et al.
Lancet (London, England)|June 15, 2020
Meningococcal disease and sexual transmission: urogenital and anorectal infections and invasive disease due to Neisseria meningitidisShamez N Ladhani, Jay Lucidarme, Sydel R Parikh, et al.
Vaccine|December 13, 2016
Concomitant administration of a fully liquid, ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal serogroup C conjugate vaccine in infantsTimo Vesikari, Ray Borrow, Xavier Da Costa, et al.
Pageof 41

Showing results (101-110 of 403) with videos related to

Sort By:
Pageof 41
Vaccine|February 12, 2022
Timing of meningococcal vaccination with 4CMenB (Bexsero®) in children with invasive meningococcal group B (MenB) disease in EnglandShamez N Ladhani, Helen Campbell, Zahin Amin-Chowdhury, et al.
The Journal of Infection|August 4, 2020
Methods to evaluate serogroup B meningococcal vaccines: From predictions to real-world evidenceRay Borrow, Muhamed-Kheir Taha, Marzia Monica Giuliani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 2013
Polysaccharide-specific memory B cells generated by conjugate vaccines in humans conform to the CD27+IgG+ isotype-switched memory B Cell phenotype and require contact-dependent signals from bystander T cells activated by bacterial proteins to differentiate into plasma cellsEdward T Clarke, Neil A Williams, Jamie Findlow, et al.
Archives of Disease in Childhood|December 17, 2015
Enter B and W: two new meningococcal vaccine programmes launchedShamez N Ladhani, Mary Ramsay, Ray Borrow, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 2, 2016
Presentation with gastrointestinal symptoms and high case fatality associated with group W meningococcal disease (MenW) in teenagers, England, July 2015 to January 2016Helen Campbell, Sydel R Parikh, Ray Borrow, et al.
Human Vaccines & Immunotherapeutics|August 27, 2020
Vaccines and routine immunization strategies during the COVID-19 pandemicEner Cagri Dinleyici, Ray Borrow, Marco Aurélio Palazzi Safadi, et al.
Vaccine|November 26, 2018
Concomitant administration of a fully liquid ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal ACWY conjugate vaccine in toddlersTimo Vesikari, Ray Borrow, Xavier Da Costa, et al.
Vaccine|August 13, 2013
Effectiveness of meningococcal serogroup C vaccine programmesRay Borrow, Raquel Abad, Caroline Trotter, et al.
Lancet (London, England)|June 15, 2020
Meningococcal disease and sexual transmission: urogenital and anorectal infections and invasive disease due to Neisseria meningitidisShamez N Ladhani, Jay Lucidarme, Sydel R Parikh, et al.
Vaccine|December 13, 2016
Concomitant administration of a fully liquid, ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal serogroup C conjugate vaccine in infantsTimo Vesikari, Ray Borrow, Xavier Da Costa, et al.
Pageof 41